ArticleFrontiers in immunology2026

Reversible cerebral vasoconstriction syndrome following ciltacabtagene autoleucel therapy for relapsed multiple myeloma: a case report.

Tuan L Phan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.